Chapters
ShareCompartir
-
Chapter 1: Diphtheria
-
Chapter 2: Haemophilus influenzae type b (Hib)
-
Chapter 3: Hepatitis A
-
Chapter 4: Hepatitis B
-
Chapter 5: Human Papillomavirus (HPV)
-
Chapter 6: Influenza
-
Chapter 7: Measles
-
Chapter 8: Meningococcal Disease
-
Chapter 9: Mumps
-
Chapter 10: Pertussis
-
Chapter 11: Pneumococcal
-
Chapter 12: Poliomyelitis
-
Chapter 13: Rotavirus
-
Chapter 14: Rubella
-
Chapter 15: Congenital Rubella Syndrome
-
Chapter 16: Tetanus
-
Chapter 17: Varicella
-
Chapter 18: Surveillance Indicators
-
Chapter 19: Enhancing Surveillance
-
Chapter 20: Analysis of Surveillance Data
-
Chapter 21: Surveillance for Adverse Events Following Immunization Using the Vaccine Adverse Event Reporting System (VAERS)
-
Chapter 22: Laboratory Support for Surveillance of Vaccine-Preventable Diseases
-
Chapter 23: National Surveillance of Vaccine-preventable Diseases
-
Chapter 24: State-specific Surveillance of Vaccine-preventable Diseases
- Page last reviewed: April 7, 2016
- Page last updated: April 7, 2016
- Content source: